新闻
CORT
--
0.00%
--
Lion Street Advisors, LLC Buys Compass Minerals International Inc, First Trust NASDAQ Rising ...
Investment company Lion Street Advisors, LLC (Current Portfolio) buys Compass Minerals International Inc, First Trust NASDAQ Rising Dividend Achievers ETF, Biomarin Pharmaceutical Inc, UnitedHealth Group Inc, Schwab Fundamental U.S.
GuruFocus.com · 01/20 14:38
Wall Street Analysts See a 26% Upside in Corcept (CORT): Can the Stock Really Move This High?
The mean of analysts' price targets for Corcept (CORT) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside i...
Zacks · 01/06 15:00
CORT vs. ZTS: Which Stock Is the Better Value Option?
CORT vs. ZTS: Which Stock Is the Better Value Option?
Zacks · 01/05 16:40
How Much Of Corcept Therapeutics Incorporated (NASDAQ:CORT) Do Insiders Own?
A look at the shareholders of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) can tell us which group is most...
Simply Wall St. · 01/01 12:38
Corcept Investor Alert
Corcept Investor Alert
NewMediaWire · 2021/12/27 23:05
Corcept 股东通知
Corcept Shareholder Notice
NewMediaWire · 2021/12/23 23:13
Federated Hermes Kaufmann Fund II Buys GXO Logistics Inc, Seres Therapeutics Inc, Domo Inc, ...
Investment company Federated Hermes Kaufmann Fund II (Current Portfolio) buys GXO Logistics Inc, Seres Therapeutics Inc, Domo Inc, Adagio Therapeutics Inc, Avalara Inc, sells Moderna Inc, Mercury Systems Inc, Ball Corp, Fidelity National Information Servic...
GuruFocus.com · 2021/12/21 06:38
Investor Alert: Corcept Shareholder
Investor Alert: Corcept Shareholder
NewMediaWire · 2021/12/19 13:16
Corcept Therapeutics Reports Prelim. Results Of Previously-Announced Tender Offer For Up To 10M Shares Of Co. Stock Between $20.75-$23.75/Share In Cash
Corcept Therapeutics Incorporated (NASDAQ:CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by
Benzinga · 2021/12/16 13:25
Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer
MENLO PARK, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders ...
GlobeNewswire · 2021/12/16 13:00
Corcept Therapeutics Announces Waiver Of Condition To Its Tender Offer For Common Shares
Corcept Therapeutics Incorporated (NASDAQ:CORT) ("Corcept"), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by
Benzinga · 2021/12/15 13:20
Corcept Therapeutics Announces Waiver of Condition to its Tender Offer for Common Shares
MENLO PARK, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders ...
GlobeNewswire · 2021/12/15 13:00
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders Corcept Therapeutics Inc. (CORT) Investigation
NEW YORK, NY / ACCESSWIRE / December 13, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Corcept Therapeutics Inc. ("Corcept" or the "Company") (NASDAQ:CORT).
ACCESSWIRE · 2021/12/13 16:30
35 Stocks Moving In Wednesday's Mid-Day Session
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.
Benzinga · 2021/12/08 17:00
Inotiv,Theravance Biopharma 引领医疗保健赢家; Radius Health 和 Ensysce Biosciences 是主要输家
Gainers: Inotiv (NASDAQ:NOTV) +13%, Theravance Biopharma (NASDAQ:TBPH) +11%, Biofrontera (NASDAQ:BFRA) +11%, Dare Bioscience (NASDAQ:DARE) +10%, Stereotaxis, Inc. (NYSE:STXS) +8%. Losers: Radius Health RDUS -43%, Ensysce Biosciences (NASDAQ:ENSC) -27%, Cor...
Seekingalpha · 2021/12/08 16:13
延长收购要约后,Corcept 跌至 52 周低点
Following a sharp decline in morning hours, the shares of Corcept Therapeutics (CORT -26.2%) have reached a 52-week low after the company extended the expiration of its previously announced tender
Seekingalpha · 2021/12/08 15:34
BRIEF-Corcept Therapeutics Announces Extension Of Previously Announced Tender Offer
reuters.com · 2021/12/08 13:18
微牛提供丰富的实时CORT股票新闻,让你可以通过多个平台了解CORT股票行情最新动态,这些免费的Corcept医疗新闻可以帮助你做出明智投资。
CORT 简况
Corcept Therapeutics Inc.是一家制药公司,从事发现、开发和销售用于治疗严重代谢、精神病和肿瘤疾病的药物。该公司专注于类固醇激素皮质醇相关的疾病。皮质醇的水平升高和异常释放能反应一系列人类疾病。该公司正在开发米非司酮,是一种通过在糖皮质激素受体(GR)上作为竞争性拮抗剂来调节皮质醇作用的化合物。它还发现3个结构上不同的选择性皮质醇调节剂系列,所有这些选择性皮质醇调节剂共享米非司酮对GR的亲和力。与米非司酮不同的是,选择性皮质醇调节剂不结合孕酮受体,因此不终止妊娠或产生与孕酮受体拮抗相关的其它副作用。该公司已经开始从事这些系列的铅化合物的临床前和临床开发业务。